» Articles » PMID: 27194029

Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods

Abstract

The tumor microenvironment is a determining factor for cancer biology and progression. Sphingosine-1-phosphate (S1P), produced by sphingosine kinases (SphKs), is a bioactive lipid mediator that regulates processes important for cancer progression. Despite its critical roles, the levels of S1P in interstitial fluid (IF), an important component of the tumor microenvironment, have never previously been measured due to a lack of efficient methods for collecting and quantifying IF. The purpose of this study is to clarify the levels of S1P in the IF from murine mammary glands and its tumors utilizing our novel methods. We developed an improved centrifugation method to collect IF. Sphingolipids in IF, blood, and tissue samples were measured by mass spectrometry. In mice with a deletion of SphK1, but not SphK2, levels of S1P in IF from the mammary glands were greatly attenuated. Levels of S1P in IF from mammary tumors were reduced when tumor growth was suppressed by oral administration of FTY720/fingolimod. Importantly, sphingosine, dihydro-sphingosine, and S1P levels, but not dihydro-S1P, were significantly higher in human breast tumor tissue IF than in the normal breast tissue IF. To our knowledge, this is the first reported S1P IF measurement in murine normal mammary glands and mammary tumors, as well as in human patients with breast cancer. S1P tumor IF measurement illuminates new aspects of the role of S1P in the tumor microenvironment.

Citing Articles

Esophageal cancer risk is influenced by genetically determined blood metabolites.

Deng J, Wu S, Huang Y, Deng Y, Yu K Medicine (Baltimore). 2024; 103(43):e40122.

PMID: 39470544 PMC: 11521038. DOI: 10.1097/MD.0000000000040122.


Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.

Nagahashi M, Miyoshi Y Int J Mol Sci. 2024; 25(6).

PMID: 38542328 PMC: 10970081. DOI: 10.3390/ijms25063354.


SARS-CoV-2 induced HDL dysfunction may affect the host's response to and recovery from COVID-19.

Al-Kuraishy H, Hussien N, Al-Niemi M, Fahad E, Al-Buhadily A, Al-Gareeb A Immun Inflamm Dis. 2023; 11(5):e861.

PMID: 37249296 PMC: 10187021. DOI: 10.1002/iid3.861.


Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells.

Wu X, Wabitsch M, Yang J, Sakharkar M PLoS One. 2023; 18(5):e0286111.

PMID: 37220155 PMC: 10204952. DOI: 10.1371/journal.pone.0286111.


Triptolide Inhibits the Biological Processes of HUVECs and HepG2 Cells via the Serine Palmitoyltransferase Long Chain Base Subunit 2/Sphingosine-1-Phosphate Signaling Pathway.

Jia L, Zhu S, Zhu M, Huang L, Xu S, Luo Y Dis Markers. 2022; 2022:9119423.

PMID: 36438896 PMC: 9699786. DOI: 10.1155/2022/9119423.


References
1.
Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G . Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010; 9(11):883-97. DOI: 10.1038/nrd3248. View

2.
Cyster J, Schwab S . Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. 2011; 30:69-94. DOI: 10.1146/annurev-immunol-020711-075011. View

3.
Takabe K, Kim R, Allegood J, Mitra P, Ramachandran S, Nagahashi M . Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010; 285(14):10477-86. PMC: 2856255. DOI: 10.1074/jbc.M109.064162. View

4.
Nagahashi M, Kim E, Yamada A, Ramachandran S, Allegood J, Hait N . Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J. 2012; 27(3):1001-11. PMC: 3574288. DOI: 10.1096/fj.12-219618. View

5.
Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J . Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2008; 23(2):405-14. PMC: 2630788. DOI: 10.1096/fj.08-117572. View